Inventor

SCHLESSINGER JOSEPH

US50 patents

⚠️ This page may combine multiple inventors who share the name “SCHLESSINGER JOSEPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHLESSINGER JOSEPH

UNIV NEW YORK

Receptor-type phosphotyrosine phosphatase-alpha

Expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins

Crystal of fibroblast growth factor receptor 1 in complex with fibroblast growth factor

Treatment of diabetes mellitus and insulin receptor signal transduction

Nucleic acid molecules encoding a novel receptor-type protein tyrosine phosphatase-σ

Receptor-type phosphotyrosine phosphatase-β

Receptor-type phosphotyrosine phosphatase-alpha

Methods for detecting tyrosine kinase-binding target proteins and identifying substances that affect SH2 phosphorylated ligand regulatory systems

Recombinant DNA encoding a eukaryotic tyrosine kinase target protein

Receptor protein tyrosine phosphatases

Receptor-type phosphotyrosine phosphatase-γ

Receptor-type phosphotyrosine phosphatase-alpha

Target proteins for eukaryotic tyrosine kinases

Method and compositions for treatment of BCR-ABL associated leukemias and other cell proliferative disorders

Methods for treatment or diagnosis of diseases or disorders associated with an APB domain

Receptor-type phosphotyrosine phosphatase-β

Receptor-type phosphotyrosine phosphatase-γ

Receptor-type phosphotyrosine phosphatase-sigma

RPTP-β antibodies

Crystals of the tyrosine kinase domain of non-insulin receptor tyrosine kinases

Adaptor protein FRS2 and related products and methods

Methods for diagnosis and treatment of PH domain signal transduction disorders

Receptor-type phosphotyrosine phosphatase-alpha

SUGEN INC

Methods for treating cancer and other cell proliferative diseases

Crystals of the tyrosine kinase domain of non-insulin receptor tyrosine kinases

PYK2 related polypeptide products

PYK2 related polynucleotide products

Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions

PYK2 and inflammation

rdgB proteins and related products and methods

RDGB proteins and related products and methods

CELLDEX THERAPEUTICS INC

Polynucleotides encoding anti-KIT antibodies

Methods of treating by administering anti-kit antibodies

Anti-KIT antibodies and uses thereof

Anti-ErbB antibodies and methods of use thereof

UNIV NEW YORK MED CT

Expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target protiens

Receptor-type phosphotyrosine phosphatase-κ

Treatment or diagnosis of diseases or conditions associated with a BLM domain

Expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins

UNIV YALE

Mutant fibroblast growth factor 21 (FGF21) polypeptides

Mutant FGF21 polypeptide compositions

Selective JAK2 pseudokinase ligands and methods of use

HADARI YARON

Anti-kit antibodies

RHONE POULENC RORER PHARMA

Human Bek Fibroblast growth factor receptor

RHONE POULENC RORER INC

Fibroblast growth factor receptors

MAX PLANCK GESSELLSCHAFT

Nucleic acid encoding novel receptor-type phosphotyrosine phosphatase-κ

UNIV NEW YORK MEDICAL CT

Adaptor protein FRS2 and related products and methods

(unassigned)

Methods for diagnosis and treatment of PH domain signal transduction disorders

MAX PLANCK GES FORGERUNG DER W

Receptor-type phosphotyrosine phosphatase-kappa antibodies

SCHLESSINGER JOSEPH

Inhibitors of receptor tyrosine kinases and methods of use thereof